Volatility ebbs as $26bn pours into option-writing ETFs - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
商业快报

Volatility ebbs as $26bn pours into option-writing ETFs

Exchange traded funds backed by covered calls draw investors in search of steady income

Investors on the hunt for regular income have this year poured almost $26bn into exchange traded funds that sell options tied to stocks, inspiring a wave of copycats and raising questions about their effects on market volatility.

The funds, known as covered call ETFs, have surged in popularity to contain roughly $59bn in combined assets, up from only $3bn three years ago, according to Morningstar Direct. The number of ETFs in the category has nearly tripled in that time to about 60 in the US.

“The zeitgeist of the retail ETF investor has moved on to income-based products and options-based products,” said Dave Mazza, chief strategy officer at Roundhill Investments, which plans to launch three covered call ETFs in the near future after dropping a strategy focused on meme stocks.

ETFs are baskets of securities like mutual funds, but which trade on exchanges and enjoy preferential tax treatment in the US. Covered call ETFs sell options on underlying equity holdings to generate income in the form of premiums while also limiting the magnitude of gains and losses. Typically seen as a defensive strategy, they’ve enjoyed continued success in a year when US markets have boomed.

About half of this year’s new money into covered call ETFs has gone to the $30bn JPMorgan Equity Premium Income ETF (JEPI), an S&P 500 index-focused product that has grown to become the largest actively managed ETF. Another $13.7bn combined has gone into a second JPMorgan covered call product and a third from Global X, both focused on the Nasdaq Composite index.

The ETFs have grown so large that some analysts believe they are beginning to influence wider financial markets by dampening the widely followed Cboe Volatility Index, or Vix.

The Vix, popularly referred to as Wall Street’s “fear gauge,” is often used as a proxy for investor expectations of stock market swings. The index is calculated based on a complex formula tied to prices in options markets. It has crept lower throughout 2023 and is hovering near levels seen before the Covid-19 pandemic.

Alex Kosoglyadov, managing director for equity derivatives at Nomura, said funds systematically selling derivatives had helped reduce volatility by increasing the supply of call options and driving down their prices.

“We’ve seen a real influx of selling from a lot of these income funds,” Kosoglyadov said, adding that “a combination of a dovish macroeconomic backdrop and this systematic selling has really compressed volatility.”

Big asset managers including Morgan Stanley and Goldman Sachs and smaller firms such as REX Shares and Roundhill have laid the groundwork in recent months for covered call ETFs of their own.

But not everyone is so keen to join the trend.

Federated Hermes, a large active fund manager that started building ETF offerings within the past few years, is unlikely to compete in the covered call arena, chief investment officer Stephen Auth said. The firm’s experience with “doing stuff that’s hot at the moment” has not been good, he added.

“The money comes rolling in and then the whole thing collapses and the clients all want to shoot us,” he said. “It’s not worth it, so we try to stay with products that we think can add value to clients over a long period of time and not try to be too cute.”

Hamilton Reiner, JPMorgan Asset Management’s head of US equity derivatives and lead manager of its JEPI ETF, contends that income generation has “always been an important part of people’s portfolios.”

“Anything that’s not feasible as an investment and sounds too good to be true, maybe it’s more faddish,” Reiner said. “But traditional call overwriting is something that’s been going on for 50 years.”

Reiner encouraged newer covered call ETF issuers to be “slightly creative” when designing products and said he was “not really against them, but I’m also not rooting for them”.

“I think there’s enough money for many winners,” he said. “I think the space will continue to grow.”

Additional reporting by Nicholas Megaw in New York

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

凯勒拉治疗学公司在生物技术领域创纪录的IPO中融资6.25亿美元

最新的生物科技公司首次公开募股创下历史新高。
15小时前

Rivian向大型汽车制造商推介软件合作

Rivian首席执行官表示,如果没有更好的软件,传统车企不可能维持其市场份额。

Mythos网络安全风波,预示AI将进入稀缺经济时代

随着前沿模型不断进化,谁能拿到这项技术,可能会变得至关重要。

日本医生警告:伊朗战争将威胁医疗物资供应

首相高市早苗下令释放手套储备,全亚洲忧虑加剧

特朗普能否将鲍威尔从美联储主席之位拉下马?

特朗普表示,如果他提名的继任者沃什在5月15日前未获确认,他将寻求解雇现任主席鲍威尔。

北约与欧盟就防务支出爆发“地盘之争”

这场争议的核心在于,欧盟资金是否应用于采购美国武器。
设置字号×
最小
较小
默认
较大
最大
分享×